Arjuna Capital Has $1.61 Million Position in Agilent Technologies, Inc. (NYSE:A)

Arjuna Capital trimmed its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 46.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,813 shares of the medical research company's stock after selling 9,231 shares during the quarter. Arjuna Capital's holdings in Agilent Technologies were worth $1,606,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its stake in Agilent Technologies by 18.2% during the first quarter. Vanguard Group Inc. now owns 29,884,345 shares of the medical research company's stock valued at $4,348,471,000 after purchasing an additional 4,605,228 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of Agilent Technologies by 13.9% in the first quarter. Price T Rowe Associates Inc. MD now owns 8,542,054 shares of the medical research company's stock valued at $1,242,956,000 after acquiring an additional 1,042,926 shares during the period. Massachusetts Financial Services Co. MA raised its stake in shares of Agilent Technologies by 5.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 15,064,660 shares of the medical research company's stock valued at $1,952,832,000 after acquiring an additional 809,149 shares during the period. Champlain Investment Partners LLC purchased a new stake in shares of Agilent Technologies in the first quarter valued at $61,218,000. Finally, Marshall Wace LLP raised its stake in shares of Agilent Technologies by 48.6% in the second quarter. Marshall Wace LLP now owns 957,128 shares of the medical research company's stock valued at $124,073,000 after acquiring an additional 313,155 shares during the period.

Analyst Ratings Changes

Several equities analysts recently commented on A shares. TD Cowen increased their price objective on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a "buy" rating in a research report on Thursday, August 22nd. Citigroup lifted their target price on shares of Agilent Technologies from $150.00 to $165.00 and gave the company a "buy" rating in a report on Thursday, August 22nd. Evercore ISI lifted their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an "in-line" rating in a research note on Tuesday, October 1st. Barclays lifted their target price on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an "underweight" rating in a research note on Tuesday, October 15th. Finally, Stifel Nicolaus reaffirmed a "buy" rating and set a $151.00 target price on shares of Agilent Technologies in a research note on Monday, August 26th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, Agilent Technologies currently has a consensus rating of "Moderate Buy" and a consensus target price of $144.36.

Insider Activity

In related news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now owns 40,011 shares of the company's stock, valued at approximately $5,801,595. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, CEO Padraig Mcdonnell sold 1,958 shares of the business's stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the sale, the chief executive officer now directly owns 24,118 shares in the company, valued at approximately $3,497,110. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Dominique Grau sold 9,990 shares of the business's stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares of the company's stock, valued at approximately $5,801,595. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 11,995 shares of company stock worth $1,739,510 over the last three months.

Agilent Technologies Price Performance

A stock traded up $0.68 during midday trading on Wednesday, reaching $134.35. 1,103,090 shares of the company's stock traded hands, compared to its average volume of 1,701,778. The company has a 50-day simple moving average of $139.17 and a two-hundred day simple moving average of $138.16. Agilent Technologies, Inc. has a 1-year low of $109.46 and a 1-year high of $155.35. The company has a market cap of $38.60 billion, a price-to-earnings ratio of 27.90, a PEG ratio of 5.88 and a beta of 1.07. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36.

Agilent Technologies (NYSE:A - Get Free Report) last released its earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The company had revenue of $1.58 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same period last year, the firm earned $1.43 EPS. The business's revenue for the quarter was down 5.6% on a year-over-year basis. On average, analysts anticipate that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, October 23rd. Stockholders of record on Tuesday, October 1st were issued a $0.236 dividend. The ex-dividend date was Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.70%. Agilent Technologies's dividend payout ratio (DPR) is 19.50%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.